Biochemical and biological characterization of the protective Leishmania pifanoi amastigote antigen P-8

Infection and Immunity

Volumn 69, Issue 11, 2001, Pages 6776-6784

  Colmenares, M ^a   Tiemeyer, M ^a   Kima, P ^a   McMahon Pratt, D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; APOLIPOPROTEIN E; CYSTEINE PROTEINASE; GLYCOLIPID; GLYCOSPHINGOLIPID; LEISHMANIA VACCINE; METALLOPROTEINASE; P 8 ANTIGEN; UNCLASSIFIED DRUG;

AMASTIGOTE; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GEL FILTRATION CHROMATOGRAPHY; LEISHMANIA; LEISHMANIA PIFANOI; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, PROTOZOAN; FEMALE; GLYCOLIPIDS; LEISHMANIA; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PROTEOLIPIDS; PROTOZOAN PROTEINS; PROTOZOAN VACCINES;

EID: 0034783621     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.11.6776-6784.2001     Document Type: Article

References (59)

1. The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages
2. Controlled field trials of a vaccine against new world cutaneous leishmaniasis
3. Expression of lipophosphoglycan, high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana
4. Isolation of lmcpc, a gene encoding a Leishmania mexicana cathepsin-B-like cysteine proteinase
5. Leishmania mexicana: Induction of metacyclogenesis by cultivation of promastigotes at acidic pH
6. Membrane glycoprotein M-2 protects against Leishmania amazonensis infection
7. Disseminated cutaneous leishmaniasis
8. Inhibition of Leishmania amastigote growth by antipain and leupeptin
9. Immunologic patterns associated with cure in human American cutaneous leishmaniasis
10. Leishmania (Leishmania) amazonensis: Purification and enzymatic characterization of a soluble serine oligopeptidase from promastigotes
11. Leishmania donovani: Long-term culture of axenic amastigotes at 37 degrees C
12. The biosynthesis, processing, and immunolocalization of Leishmania pifanoi amastigote cysteine proteinases
13. Extracellular amastigote-like forms of Leishmania panamensis and L. braziliensis. II. Stage- and species-specific monoclonal antibodies
14. Extracellular cultivation and morphological characterization of amastigote-like forms of Leishmania panamensis and L. braziliensis
15. Glycerophosphoryl diglucosyl diglyceride, a new phosphoglycolipid from Streptococci
16. The major surface glycoprotein (GP63) is present in both life stages of Leishmania
17. Intracellular differentiation of Leishmania amazonensis promastigotes to amastigotes: Presence of megasomes, cysteine proteinase activity and susceptibility to leucine-methyl ester
18. Leishmaniases of the New World: Current concepts and implications for future research
19. Follow-up study of a vaccination programme against cutaneous leishmaniasis. I. Vaccination with a 5 year-old human strain of L. tropica from the Negev
20. Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis
21. Monosaccharide analysis of glycoconjugates by anion exchange chromatography with pulsed amperometric detection
22. Structure and expression of mouse apolipoprotein E gene
23. Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection
24. Immunoprotective Leishmania major synthetic T cell epitopes
25. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization
26. Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells
27. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
28. 125I-labeled toxin to thin-layer chromatograms
29. Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids
30. The glycoinositol phospholipids of Leishmania mexicana promastigotes. Evidence for the presence of three distinct pathways of glycolipid biosynthesis
31. The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes
32. Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection
33. The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stage
34. Examination of variables in the vaccination of mice against cutaneous leishmaniasis using living avirulent cloned lines and killed promastigotes of Leishmania major
35. Glycosyl phosphatidylinositol myristoylation in African trypanosomes. New intermediates in the pathway for fatty acid remodeling
36. The multiple cpb cysteine proteinase genes of Leishmania mexicana encode isoenzymes that differ in their stage regulation and substrate preferences
37. Vaccination of humans against cutaneous leishmaniasis: Cellular and humoral immune responses
38. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants
39. Leishmania mexicana pifanoi: Antigenic characterization of promastigote and amastigote stages by solid phase radioimmunoassay
40. Leishmania mexicana: Proteinase activities and megasomes in axenically cultivated amastigote-like forms
41. Purification and characterization of proteolytic enzymes of Leishmania mexicana mexicana amastigotes and promastigotes
42. Cathepsin B-like cysteine proteases of Leishmania mexicana
43. Multiple high activity cysteine proteases of Leishmania mexicana are encoded by the Imcpb gene array
44. Immunity to leishmaniasis: What properties delineate a protective antigen?
45. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes
46. Serine proteases from nematode and protozoan parasites: Isolation of sequence homologs using generic molecular probes
47. Leishmania major: Differential regulation of the surface metalloprotease in amastigote and promastigote stages
48. Identification of T-ceil-reactive antigens that protect BALB/c mice against Leishmania major
49. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes
50. Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subfractions of soluble promastigote extract
51. Zwitterionic and acidic glycosphingolipids of the Drosophila melanogaster embryo
52. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis
53. Enzymatic digestion of proteins and HPLC peptide isolation
54. Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages
55. A procedure for the quantitative isolation of brain gangliosides
56. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
57. Surface antigens of Leishmania mexicana amastigotes: Characterization of glycoinositol phospholipids and a macrophage-derived glycosphingolipid
58. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis
59. Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major